ISSN: 2155-6199

Journal of Bioremediation & Biodegradation

Bioremediation Products

Search results for
Bioremediation Products

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 7718

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Ulrich's Periodicals Directory
  • Access to Global Online Research in Agriculture (AGORA)
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Publons
  • Geneva Foundation for Medical Education and Research
  • MIAR
  • ICMJE
Share This Page

Bioremediation Products

Alabaster Corp. Bioremediation Products for oil spill cleaning, Bio Tech, Inc. leads the industry in the use of microorganisms to improve the performance of oil & gas producing wells, SWDs and waterfloods. Biohidrica; Developer of products for the detection and control of environmental contamination.

Related Journals of Bioremediation Products

Natural Products Chemistry & Research,Journal of Molecular Pharmaceutics & Organic Process Research,Journal of Pharmacognosy & Natural Products,Journal of Natural Products,Journal of Asian Natural Products Research,Studies in Natural Products Chemistry,Records of Natural Products

Bioremediation Products

Speaker PPTs

  • Dalia Sekmokiene
    Antimicrobial, antioxidative, phytochemical and functional characteristics of the extracts of some plants and spices seeking to adapt them as a potential source of biologically active substances for the safety of dairy products
    | PDF Version
  • Alexandra Emelyanova
    Released-active antibodies are innovative products for the effective management of severe respiratory viral infections
    | PDF Version
  • Chang-Hung Chou
    Diversified natural products in Rhododendron formosanum reveal allelochemical and pharmaceutical properties
    | PDF Version
  • Yi-Cheng Hu
    Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifentreated female breast cancer survivors in Taiwan between 1998 and 2008: A population-based study
    | PDF Version
  • Carsten Worsoe
    The value of the “simulated study” as a tool to predict actual leachables in parenteral drug products
    | PDF Version
  • Diane Paskiet
    Qualifi cation of extractables & leachables from container closure systems in drug products- Introduction to the Product Quality Institute (PQRI) recommendations
    | PDF Version
  • Neervalur V Raghavan
    Systematic approach to development of aqueous drug formulation and drug device combination injectable products and challenges
    | PDF Version
  • Jianfeng Hong
    Extractable and leachable studies of parenteral infusion and transfusion products
    | PDF Version
  • Heidi Schalchli
    Natural products of Anthracophyllum discolor: Ligninolytic enzymes and antifungal volatile compounds
    | PDF Version
  • Shree Kumar Apte
    Genetic engineering of Deinococcus radiodurans for uranium bioremediation from high radiation environment
    | PDF Version
  • Hazel Gorham
    Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
    | PDF Version
  • Yosef Yarden
    Classically, the 3’untranslated region (3’UTR) is that region in eukaryotic protein-coding genes from the translation termination codon to the polyA signal. It is transcribed as an integral part of the mRNA encoded by the gene. However, there exists another kind of RNA, which consists of the 3’UTR alone, without all other elements in mRNA such as 5’UTR and coding region. The importance of independent 3’UTR RNA (referred as I3’UTR) was prompted by results of artificially introducing such RNA species into malignant mammalian cells. Since 1991, we found that the middle part of the 3’UTR of the human nuclear factor for interleukin-6 (NF-IL6) or C/EBP gene exerted tumor suppression effect in vivo. Our subsequent studies showed that transfection of C/EBP 3’UTR led to down-regulation of several genes favorable for malignancy and to up-regulation of some genes favorable for phenotypic reversion. Also, it was shown that the sequences near the termini of the C/EBP 3’UTR were important for its tumor suppression activity. Then, the C/EBP 3’UTR was found to directly inhibit the phosphorylation activity of protein kinase CPKC in SMMC-7721, a hepatocarcinoma cell line. Recently, an AU-rich region in the C/EBP 3’UTR was found also to be responsible for its tumor suppression. Recently we have also found evidence that the independent C/EBP 3’UTR RNA is actually exists in human tissues, such as fetal liver and heart, pregnant uterus, senescent fibroblasts etc. Through 1990’s to 2000’s, world scientists found several 3’UTR RNAs that functioned as artificial independent RNAs in cancer cells and resulted in tumor suppression. Interestingly, majority of genes for these RNAs have promoter-like structures in their 3’UTR regions, although the existence of their transcribed products as independent 3’UTR RNAs is still to be confirmed. Our studies indicate that the independent 3’UTR RNA is a novel non-coding RNA species whose function should be the regulation not of the expression of their original mRNA, but of some essential life activities of the cell as a whole.
    | PDF Version
  • Hyeun-Jong Bae
    Onion waste recycling to produce the value added by-products
    | PDF Version
  • Kazuo Yano
    Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and Japan
    | PDF Version
  • C. Diaz
    New Antibacterial Agents against Gram-negative Pathogens from a Fundacion MEDINA’s Microbial Natural Products Collection Screening
    | PDF Version
  • Szabolcs Peter
    Vitamin E - Emerging benefits
    | PDF Version
  • Daniel Raederstorff
    Nutritional solutions to counteract impact of air pollution
    | PDF Version
  • Thomas J Franz
    Assessing the BA and BE of Topical Dermatologic Drug Products with Multiple Surrogate Methods
    | PDF Version
  • Cemalettin Saricoban
    The effects of various milk bi products on microbial properties of beef patties
    | PDF Version
  • Zahariah Ismail
    The benefit of palm tocotrienols in personal care products
    | PDF Version
  • Eva Skrivanova
    Alternatives to in-feed antibiotics and their impact on the safety of animal products
    | PDF Version
  • Mona Mohammed
    Key considerations of orphan products designation and registration regulation
    | PDF Version
  • Harun Rasit Uysal
    European and Turkish dairy sector: Traditional dairy products at a glance
    | PDF Version
  • Eman H.Abdel-Rahman
    Induction of protective cellular and humoral responses against fasciolosis in rabbits using immunoaffinity fraction of Fasciola gigantica excretory secretory products
    | PDF Version
  • Osama Ibrahim
    Oligosaccharides: An overview of beneficial sweeteners for food products
    | PDF Version
High Impact List of Articles
Conference Proceedings